Evoke Pharma Shares Double Following Agreement to Be Acquired by QOL Medical for $11 Per Share

QOL Medical buys Evoke Pharma for $11/share (140% premium). Evoke sells GIMOTI, a key nasal spray for diabetic stomach issues.